GMED
Price
$87.06
Change
-$0.39 (-0.45%)
Updated
Feb 4 closing price
Capitalization
11.65B
14 days until earnings call
Intraday BUY SELL Signals
PEN
Price
$339.92
Change
-$16.08 (-4.52%)
Updated
Feb 4 closing price
Capitalization
13.33B
19 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GMED vs PEN

Header iconGMED vs PEN Comparison
Open Charts GMED vs PENBanner chart's image
Globus Medical
Price$87.06
Change-$0.39 (-0.45%)
Volume$1.72M
Capitalization11.65B
Penumbra
Price$339.92
Change-$16.08 (-4.52%)
Volume$1.41M
Capitalization13.33B
GMED vs PEN Comparison Chart in %
View a ticker or compare two or three
VS
GMED vs. PEN commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a Buy and PEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (GMED: $87.06 vs. PEN: $339.92)
Brand notoriety: GMED and PEN are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: GMED: 119% vs. PEN: 135%
Market capitalization -- GMED: $11.65B vs. PEN: $13.33B
GMED [@Medical/Nursing Services] is valued at $11.65B. PEN’s [@Medical/Nursing Services] market capitalization is $13.33B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $188.15B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green whilePEN’s FA Score has 0 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • PEN’s FA Score: 0 green, 5 red.
According to our system of comparison, PEN is a better buy in the long-term than GMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 4 TA indicator(s) are bullish while PEN’s TA Score has 4 bullish TA indicator(s).

  • GMED’s TA Score: 4 bullish, 5 bearish.
  • PEN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PEN is a better buy in the short-term than GMED.

Price Growth

GMED (@Medical/Nursing Services) experienced а -5.19% price change this week, while PEN (@Medical/Nursing Services) price change was -5.32% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.38%. For the same industry, the average monthly price growth was -2.45%, and the average quarterly price growth was +13.17%.

Reported Earning Dates

GMED is expected to report earnings on Feb 19, 2026.

PEN is expected to report earnings on Feb 24, 2026.

Industries' Descriptions

@Medical/Nursing Services (+3.38% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PEN($13.3B) has a higher market cap than GMED($11.7B). PEN has higher P/E ratio than GMED: PEN (81.13) vs GMED (28.17). PEN YTD gains are higher at: 9.331 vs. GMED (-0.286). GMED has higher annual earnings (EBITDA): 710M vs. PEN (205M). PEN has more cash in the bank: 470M vs. GMED (391M). GMED has less debt than PEN: GMED (119M) vs PEN (217M). GMED has higher revenues than PEN: GMED (2.77B) vs PEN (1.33B).
GMEDPENGMED / PEN
Capitalization11.7B13.3B88%
EBITDA710M205M346%
Gain YTD-0.2869.331-3%
P/E Ratio28.1781.1335%
Revenue2.77B1.33B208%
Total Cash391M470M83%
Total Debt119M217M55%
FUNDAMENTALS RATINGS
GMED vs PEN: Fundamental Ratings
GMED
PEN
OUTLOOK RATING
1..100
6424
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
6958
SMR RATING
1..100
7058
PRICE GROWTH RATING
1..100
4339
P/E GROWTH RATING
1..100
9999
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GMED's Valuation (74) in the Medical Specialties industry is in the same range as PEN (82). This means that GMED’s stock grew similarly to PEN’s over the last 12 months.

PEN's Profit vs Risk Rating (58) in the Medical Specialties industry is in the same range as GMED (69). This means that PEN’s stock grew similarly to GMED’s over the last 12 months.

PEN's SMR Rating (58) in the Medical Specialties industry is in the same range as GMED (70). This means that PEN’s stock grew similarly to GMED’s over the last 12 months.

PEN's Price Growth Rating (39) in the Medical Specialties industry is in the same range as GMED (43). This means that PEN’s stock grew similarly to GMED’s over the last 12 months.

PEN's P/E Growth Rating (99) in the Medical Specialties industry is in the same range as GMED (99). This means that PEN’s stock grew similarly to GMED’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GMEDPEN
RSI
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
58%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 15 days ago
65%
Bullish Trend 14 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
71%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
GMED
Daily Signal:
Gain/Loss:
PEN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TAN58.102.51
+4.52%
Invesco Solar ETF
MDPL27.440.47
+1.74%
Monarch Dividend Plus ETF
XSVN47.73-0.02
-0.04%
BondBloxx Bloomberg SevenYrTrgDurUSTrETF
MFSG27.17-0.48
-1.74%
MFS Active Growth ETF
FETH21.60-1.31
-5.72%
Fidelity Ethereum Fund

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been closely correlated with SENS. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if GMED jumps, then SENS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
-0.45%
SENS - GMED
71%
Closely correlated
+1.40%
PAVM - GMED
68%
Closely correlated
+7.21%
AXGN - GMED
67%
Closely correlated
-2.81%
MOVE - GMED
66%
Loosely correlated
+4.87%
INBS - GMED
64%
Loosely correlated
-6.14%
More

PEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEN has been loosely correlated with INBS. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PEN jumps, then INBS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEN
1D Price
Change %
PEN100%
-4.52%
INBS - PEN
63%
Loosely correlated
-6.14%
AXGN - PEN
59%
Loosely correlated
-2.81%
GMED - PEN
55%
Loosely correlated
-0.45%
CERS - PEN
46%
Loosely correlated
-2.14%
BSX - PEN
45%
Loosely correlated
-17.59%
More